As a new-type foreign trade service provider driven by both technological transformation and foreign trade services, HiSiaddi has established a "1+2+3+4=1" service system and can supply D Psicose sourced directly from multiple well-known original manufacturers.
As a research-and-development-oriented foreign trade enterprise, HiSiaddi does not only promote its own factory’s technology like single-brand manufacturers. We objectively analyze multiple domestic and global brands with high market share and share their landmark process advancements and breakthroughs, enabling buyers to access authentic, up-to-date market intelligence.
If you require more comprehensive and valuable D Psicose market insights, please contact HiSiaddi customer service.
1. Bailong Chuangyuan: Directed evolution modification of DAE isomerase lifts single-pass conversion rate of fructose to D Psicose from the traditional industry benchmark of 32% to 89.2%, breaking thermodynamic conversion bottlenecks. Synchronous optimization of continuous chromatographic purification delivers crystalline products with stable purity up to 99.6% (surpassing the national standard maximum of 99.5%), removing purity barriers for high-end medical food raw material supply.
2. Sanyuan Biology: AI intelligent strain directional screening technology is fully deployed, raising isomerase catalytic conversion rate from 50% to 65% and cutting fructose consumption per ton of output by 28%. Supporting immobilized enzyme regeneration technology extends enzyme recyclability from 3 cycles to 16 cycles, directly reducing enzyme procurement costs by 30%.
3. COFCO Technology: Self-developed high-temperature-resistant isomerase maintains stable activity at 58°C (conventional industry enzymes cap out at 45°C). High-temperature continuous conversion shortens process duration by 42%, compressing batch production cycles from 72h to 41h and boosting single-line daily output by 55%.
4. Baolingbao: Self-owned strains paired with custom in-house enzyme preparations deliver isomerization efficiency 21% above industry averages. Full DCS intelligent central control production lines cut process loss rates from 8.7% to 2.3%, significantly optimizing comprehensive raw material utilization.
5. Weiyuan Synthesis: World-first AS10 engineered strain one-step fermentation process eliminates the intermediate "glucose → fructose" stage, directly producing D Psicose from corn starch. The raw material conversion pathway is streamlined from three steps to one, with comprehensive fermentation yield reaching 59% – breaking the monopoly of traditional dual-enzyme processes.
Downstream Benefits: Reduced raw material unit consumption lowers FOB prices of domestic spot goods by 27%–33% year-on-year versus 2024, cutting overseas buyers’ raw material stocking costs. High-purity spot products directly meet European and American pharmacopoeia and food-grade access standards, eliminating secondary refining expenses for downstream manufacturers.
1. Cost Breakthroughs: Process iteration across the five leading domestic manufacturers reduces average industry production costs from RMB 22,000/ton to RMB 13,500–15,500/ton. Upon full mass production of Weiyuan Synthesis’s CRISPR strain iteration technology, long-term production costs are projected to drop below RMB 10,000/ton, approaching erythritol cost ranges. Bailong Chuangyuan’s Thailand overseas production base avoids 34% U.S. import tariffs, cutting comprehensive import tax costs for North American clients by 34%.
2. Low-Carbon Breakthroughs: Baolingbao completed full-process carbon reduction renovations for its smart factory, cutting unit product carbon emissions by 89% relative to legacy production lines. All five brands obtained EU carbon footprint accounting certifications, meeting carbon neutral supply chain tender requirements for European and American brands.
Downstream Benefits: Buyers access low-cost raw materials, reduced import tariffs and low-carbon supply chain certifications simultaneously, satisfying carbon neutral tender thresholds for European and American supermarkets and leading food enterprises and strengthening ESG compliance competitiveness of end products.
1. Liquid D Psicose: Bailong Chuangyuan and Baolingbao pioneered high-solids liquid production technology, manufacturing 75% high-concentration syrup with zero crystallization after 6 months of ambient storage, enabling direct in-situ feeding for beverage production and eliminating buyers’ dissolution processing steps.
2. Ultra-Fine Crystals (2000 mesh): Sanyuan Biology and COFCO Technology developed ultra-fine pulverization refined products with 72% faster dissolution rates, ideal for dry blending production of milk powder and meal replacement powders.
3. Medical Food-Grade Ultra-High Purity Products: Weiyuan Synthesis’s fermentation-derived products limit miscellaneous impurities (polysaccharides, fructose residues) ≤0.12%, passing U.S. GRAS supplementary certification and EU Novel Food pre-approval with authorization for infant supplementary food and low-GI medical food formulations.
Downstream Benefits: Buyers eliminate independent blending and modification requirements, with a single raw material covering four major categories – beverages, baking, dairy and medical food – lowering multi-ingredient warehousing and stocking costs. Ultra-high-purity medical food grades unlock incremental bulk orders for overseas low-GI health supplements and blood sugar control pharmaceutical excipients.
2025–2026 concentrated certification milestones include U.S. GRAS, South Korea KFDA, ASEAN food additive registration and Australia FSANZ full-category market access. Baolingbao and COFCO Technology completed domestic substantial equivalence reviews, verifying domestic product quality indicators match established European and American brands with a 100% customs sampling inspection pass rate for overseas imports.
Downstream Benefits: Buyers distributing across multiple countries avoid separate raw material safety registrations, shortening new product launch cycles by 3–6 months.
1. Tate&Lyle (UK): Third-generation immobilized isomerase mass production delivers 22 enzyme recycling cycles (up from 8 cycles for the prior generation), cutting enzyme consumption per ton of product by 61% and lowering North American local production costs by 22%. Continuous membrane separation purification replaces intermittent chromatography, narrowing batch color fluctuation range from ±3% to ±0.5% and drastically improving batch-to-batch raw material stability.
2. Cargill (USA): Multi-enzyme cascade new process deployed at German production facilities couples staged fructose conversion, lifting total conversion rate from 52% to 79.5% and shortening European local spot delivery lead times from 28 days to 12 days.
3. Bonumose (USA): Successfully mass-produced a novel direct conversion process using plant-based maltodextrin as feedstock (non-fructose raw material route), decoupling production from high-fructose corn syrup price volatility and expanding raw material sourcing options by three varieties to strengthen resistance against raw material price hikes.
4. CJ CheilJedang (South Korea): Low-temperature-resistant isomerase deployed at Indonesian production lines eliminates temperature control requirements for tropical ambient workshops, cutting energy consumption by 35% and reducing Southeast Asian FOB quotations by 18%.
5. Matsutani (Japan): Optimized coupled natural extraction + enzymatic conversion processes boost retention of natural trace flavor components by 83%, delivering flavor nearly identical to natural sucrose. High-end baking and chocolate formulations can replace sucrose without additional flavor adjustment.
Downstream Benefits: Improved spot supply stability across European, American and Southeast Asian regions reduces price lock-in stocking risks for buyers. Multi-feedstock product variants enable targeted selection to avoid cost volatility from single raw material price surges.
1. Tate&Lyle: Heat-resistant modified D Psicose resists browning and caramelization after 30 minutes of baking at 190°C, resolving discoloration pain points of conventional sugar substitutes for cookies, pastries and other high-temperature baked goods.
2. Matsutani: Low-hygroscopic modified powder avoids agglomeration for 3 months under 65% ambient humidity, suitable for open-bulk snack food production.
3. Cargill: Slow-release D Psicose granules deliver gradual intestinal sweetness, optimized for sugar-free compressed candy and functional dietary supplement applications.
Downstream Benefits: End formulators directly substitute sucrose without modifying legacy production equipment or formulation systems, cutting R&D costs for formula iteration by over 60%.
Tate&Lyle and Cargill completed pharmaceutical excipient registration for D Psicose (listed in the U.S. USP Pharmacopoeia) and cosmetic moisturizing raw material market access, securing universal ingredient certifications across food, pharmaceutical and cosmetic sectors. A single raw material supports cross-industry export sales.
Downstream Benefits: Buyers supply food manufacturers, pharmaceutical factories and skincare brands from a unified raw material source, expanding downstream client coverage and increasing single-product order volume.
1. Procurement Cost Side: Process-driven cost reductions across domestic and global leading manufacturers drive a 28%–35% year-on-year decline in global D Psicose market prices for 2026, significantly compressing raw material procurement costs for end food producers and expanding product pricing flexibility.
2. Production Side: Full coverage of modified multi-specification new products delivers plug-and-play performance for beverages, baking, dairy, medical food and cosmetic applications, eliminating pre-processing and blending steps and lowering factory energy and labor costs.
3. Compliance Distribution Side: Complete cross-border compliance certifications for domestic and global products enable buyers to distribute to multiple global markets with streamlined procedures, drastically shortening new product launch cycles.
4. End Product Side: High-purity, sucrose-like flavor D Psicose empowers end products to carry low-glycemic, low-calorie and all-natural labeling, aligning with global sugar reduction consumption trends and lifting average end-product sales velocity by over 25%.
If you require more comprehensive and valuable D Psicose market insights, please contact HiSiaddi customer service.
+86-13120989737 
info@hisiaddi.com 
English
